HK1215969A1 - 用於检测抗生物制品治疗的中和性自身抗体的测定 - Google Patents

用於检测抗生物制品治疗的中和性自身抗体的测定 Download PDF

Info

Publication number
HK1215969A1
HK1215969A1 HK16103834.6A HK16103834A HK1215969A1 HK 1215969 A1 HK1215969 A1 HK 1215969A1 HK 16103834 A HK16103834 A HK 16103834A HK 1215969 A1 HK1215969 A1 HK 1215969A1
Authority
HK
Hong Kong
Prior art keywords
neutralizing
therapy
present
biologic
assays
Prior art date
Application number
HK16103834.6A
Other languages
English (en)
Chinese (zh)
Inventor
Scott Hauenstein
Sharat Singh
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/802,117 external-priority patent/US20130266963A1/en
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of HK1215969A1 publication Critical patent/HK1215969A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK16103834.6A 2012-11-30 2013-11-27 用於检测抗生物制品治疗的中和性自身抗体的测定 HK1215969A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261732251P 2012-11-30 2012-11-30
US61/732,251 2012-11-30
US13/802,117 US20130266963A1 (en) 2011-07-06 2013-03-13 Assay for detecting neutralizing autoantibodies to biologic therapy
US13/802,117 2013-03-13
PCT/IB2013/060458 WO2014083520A2 (en) 2012-11-30 2013-11-27 Assays for detecting neutralizing autoantibodies to biologic therapy

Publications (1)

Publication Number Publication Date
HK1215969A1 true HK1215969A1 (zh) 2016-09-30

Family

ID=50828561

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103834.6A HK1215969A1 (zh) 2012-11-30 2013-11-27 用於检测抗生物制品治疗的中和性自身抗体的测定

Country Status (13)

Country Link
EP (1) EP2926136A2 (enExample)
JP (1) JP2016502091A (enExample)
KR (1) KR20150088890A (enExample)
CN (1) CN105074461A (enExample)
AU (1) AU2013350817A1 (enExample)
BR (1) BR112015012482A2 (enExample)
CA (1) CA2892766A1 (enExample)
HK (1) HK1215969A1 (enExample)
IL (1) IL238995A0 (enExample)
MX (1) MX2015006852A (enExample)
RU (1) RU2015125739A (enExample)
SG (2) SG11201504097PA (enExample)
WO (1) WO2014083520A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010315547C1 (en) 2009-10-26 2015-06-04 Société des Produits Nestlé S.A. Assays for the detection of anti-TNF drugs and autoantibodies
AU2011317149B2 (en) 2010-10-18 2015-05-07 Société des Produits Nestlé S.A. Methods for determining anti-drug antibody isotypes
RU2013158256A (ru) 2011-07-06 2015-07-10 Нестек С.А. АНАЛИЗЫ ДЛЯ ОБНАРУЖЕНИЯ НЕЙТРАЛИЗУЮЩИХ АУТОАНТИТЕЛ ДЛЯ БИОЛОГИЧЕСКОЙ ТЕРАПИИ TNFα
ES2735085T3 (es) 2014-12-05 2019-12-16 Nestle Sa Ensayos de cambio de movilidad homogéneos indirectos para la detección de agentes biológicos en muestras de pacientes
US11085931B2 (en) 2015-01-09 2021-08-10 W. Health L.P. Universal assay for determining the quantity of TNFα inhibitory drugs and their corresponding anti-drug-antibodies
EP3482199A1 (en) * 2016-07-08 2019-05-15 Atonomics A/S A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples
AU2018241286B2 (en) 2017-03-31 2025-03-13 Ablynx N.V. Improved immunogenicity assays
JP7570421B2 (ja) * 2020-01-02 2024-10-21 エフ． ホフマン－ラ ロシュ アーゲー Ａｄａ応答特定アッセイ
CN111024958B (zh) * 2020-03-11 2020-06-23 同昕生物技术（北京）有限公司 用于检测单抗药物和抗单抗药物抗体的试剂及其应用
CN112730846B (zh) * 2020-12-18 2023-12-15 安渡生物医药(杭州)有限公司 一种用于小鼠血样检测免疫复合物的方法
CN114047343B (zh) * 2022-01-13 2022-05-31 美迪西普亚医药科技(上海)有限公司 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用
CN117871856A (zh) * 2023-12-15 2024-04-12 首都医科大学附属北京地坛医院 可溶性因子在无症状神经梅毒检测中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010315547C1 (en) * 2009-10-26 2015-06-04 Société des Produits Nestlé S.A. Assays for the detection of anti-TNF drugs and autoantibodies
CN102884433A (zh) * 2010-04-29 2013-01-16 塞拉蒂亚戈公司 用于检测抗体的方法
AU2011317149B2 (en) * 2010-10-18 2015-05-07 Société des Produits Nestlé S.A. Methods for determining anti-drug antibody isotypes
ES2530175T3 (es) * 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
RU2013158256A (ru) * 2011-07-06 2015-07-10 Нестек С.А. АНАЛИЗЫ ДЛЯ ОБНАРУЖЕНИЯ НЕЙТРАЛИЗУЮЩИХ АУТОАНТИТЕЛ ДЛЯ БИОЛОГИЧЕСКОЙ ТЕРАПИИ TNFα

Also Published As

Publication number Publication date
WO2014083520A3 (en) 2014-07-31
RU2015125739A (ru) 2017-01-13
JP2016502091A (ja) 2016-01-21
IL238995A0 (en) 2015-07-30
MX2015006852A (es) 2015-09-16
WO2014083520A2 (en) 2014-06-05
BR112015012482A2 (pt) 2017-07-11
CN105074461A (zh) 2015-11-18
KR20150088890A (ko) 2015-08-03
SG11201504097PA (en) 2015-06-29
AU2013350817A1 (en) 2015-06-11
SG10201703210XA (en) 2017-06-29
CA2892766A1 (en) 2014-06-05
EP2926136A2 (en) 2015-10-07

Similar Documents

Publication Publication Date Title
WO2014083520A3 (en) Assays for detecting neutralizing autoantibodies to biologic therapy
MX343324B (es) Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha.
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
MX390772B (es) Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias.
BR112014031365A2 (pt) métodos de detectar doenças ou condições
WO2014153099A3 (en) Method for using exhaled breath to determine the presence of drug
BRPI1007321A2 (pt) métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo.
EP2839266A4 (en) METHOD AND SYSTEMS FOR DETECTING AN ANALYTE OR CLASSIFYING A SAMPLE
EP2972333A4 (en) BIOSENSOR DEVICE FOR TESTING ON ANALYTES IN SITU, IN VIVO, AND / OR IN REAL TIME AND METHOD FOR THE PRODUCTION AND USE THEREOF
MX349561B (es) Método para detectar nucleosomas que contienen variantes de histonas.
MX343328B (es) Analisis para la deteccion de farmacos anti-tnf y anticuerpos.
EP2973475A4 (en) METHOD AND DEVICES FOR DETECTING INCONTINENCE OR OTHER MOISTURE, METHOD FOR LIQUID ANALYSIS AND MULTIFUNCTIONAL SENSOR SYSTEMS
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
BR112015003046A2 (pt) sistema de neurofeedback, processador de sinal para determinação de uma característica do sinal do sinal do biofeedback medido, método para provisão de um usuário com o neurofeedback e programa de computador.
EP2569635A4 (en) METHOD FOR DIAGNOSIS AND / OR TREATMENT OF ENZEPHALITIS OR EPILEPSY
HK1213892A1 (zh) Tec家族激酶抑制剂疗法的伴随诊断
WO2015042326A3 (en) Methods for detection and treatment of neurodegenerative diseases
SG10201806729VA (en) Novel assay to detect human periostin
BR112013013457A2 (pt) métodos para identificar um paciente ou sujeito, para prever a sensibilidade de um sujeito, para identificar sujeitos que têm doença de parkinson e para determinar a resposta do sujeito à terapia e ensaio para seleção de compostos e composições
WO2015070191A3 (en) Systems and methods for detection of genomic variants
WO2011085057A3 (en) Methods for detecting insulin autoantibody
WO2015077342A3 (en) Detection of arginine methylation of egfr for prediction of resistance to therapy
HK1205789A1 (en) Method for selecting or identifying a subject for v1b antagonist therapy
IN2014KN00742A (enExample)
WO2013101276A3 (en) Diagnosis and detection of disease conditions modulated by activation of the sphingolipid pathway